Mycophenolate Mofetil Tablets 0.5g – For Laboratory Research Only

描述

Mycophenolate Mofetil is the prodrug of mycophenolic acid (MPA), an immunosuppressive agent frequently studied in models of organ transplantation, autoimmune disease, and lymphocyte proliferation.

Manufactured by Zhejiang Hisun Pharmaceutical Co., Ltd., these tablets contain 0.5g of mycophenolate mofetil each, with 100 tablets per bottle. Approved by China’s NMPA under license number H20070082, and registered with the drug code 86904641002419, this product is suitable for use in research focusing on cellular immunity modulation and rejection mechanisms.

?? Note: This product is intended strictly for laboratory research use only. Not for use in humans or animals.

Product Specifications

Mechanism of Action & Research Applications

Mycophenolate mofetil is hydrolyzed to mycophenolic acid (MPA), which selectively inhibits inosine monophosphate dehydrogenase (IMPDH). This enzyme is vital for de novo guanine nucleotide synthesis in lymphocytes, thereby inhibiting T and B cell proliferation.

Common research applications include:

• Immunosuppressive mechanism modeling

• Organ transplant rejection studies

• Autoimmune response suppression

• Lymphocyte cell cycle inhibition

• Pharmacokinetics and resistance profiling

Mycophenolate is often used alongside cyclosporine or tacrolimus in combined immunosuppressive protocols.

Side Effects (For Reference Only in Models)

In laboratory studies or animal models, Mycophenolate Mofetil may lead to:

• Gastrointestinal disturbances (e.g., diarrhea, nausea)

• Suppression of bone marrow activity

• Increased susceptibility to infections

• Hepatic enzyme alterations

• Potential teratogenicity in reproductive models

These are observations from preclinical studies and are not indicative of clinical use.

Disclaimer

This product is intended exclusively for laboratory research purposes. It is not for human or veterinary use, diagnosis, or treatment. Appropriate safety and handling procedures must be followed in compliance with institutional and national guidelines.